市場調査レポート
商品コード
1413716

欧州の遺伝子編集技術市場:分析・予測、2023-2032年

Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032

出版日: | 発行: BIS Research | ページ情報: 英文 93 Pages | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
欧州の遺伝子編集技術市場:分析・予測、2023-2032年
出版日: 2024年01月23日
発行: BIS Research
ページ情報: 英文 93 Pages
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の遺伝子編集技術の市場規模は、2023年の3億7,000万米ドルから、予測期間中は27.24%のCAGRで推移し、2032年には32億6,000万米ドルの規模に達すると予測されています。 遺伝子編集技術市場は、主に個別化医療に対する需要の高まりにより成長が見込まれています。

さらに、新規技術のイントロダクションがこの市場の拡大をさらに促進しています。

主要市場統計
予測期間 2023-2032年
2023年評価 3億7,000万米ドル
2032年予測 32億6,000万米ドル
CAGR 27.24%

欧州の遺伝子編集技術の市場は、個別化医療に対する需要の高まりと先進技術の導入を原動力に著しい成長を遂げています。遺伝子編集技術は、個々の患者に合わせて医療処置を調整し、より効果的な治療法を提供する可能性があるとして脚光を浴びています。さらに、新たな遺伝子編集技術の出現により、精度と効率が向上し、欧州での研究や臨床応用の価値が高まっています。同地域は科学研究、バイオテクノロジー、支援的な規制枠組みへの取り組みが強固であるため、遺伝子編集技術の導入に適した環境が整っています。倫理的で責任ある遺伝子編集の実践は、この市場の持続的成長をさらに確実なものにしています。遺伝子編集がヘルスケアとライフサイエンスを変革し続ける中、欧州の遺伝子編集技術市場は科学の進歩と治療イノベーションのための有望な機会を提示しています。

当レポートでは、欧州の遺伝子編集技術の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、製品ベンチマーキング、技術・特許の動向、市場規模の推移・予測、各種区分・主要国別の詳細分析、主要企業の分析などをまとめています。

市場の分類

セグメンテーション1:技術別

  • CRISPR遺伝子編集技術
  • 非CRISPR遺伝子編集技術

セグメンテーション2:用途別

  • 農業
  • バイオ医療

セグメンテーション3:国別

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • スイス
  • その他

目次

エグゼクティブサマリー

第1章 製品の定義

第2章 市場の範囲

第3章 調査手法

第4章 市場概要

  • 市場概要
  • 市場のフットプリントと潜在的な成長シナリオ
  • 遺伝子編集技術の進化
  • 臨床試験

第5章 業界の展望

  • 規制状況
  • 欧州の法的要件と枠組み
  • 世界の迅速指定
  • 製品ベンチマーキング
  • 技術導入マトリックス
  • 業界の動向
  • 特許分析

第6章 欧州

  • 概要
  • 欧州
    • 欧州の遺伝子編集技術市場(用途別)
    • 欧州の遺伝子編集技術市場(技術別)
    • 欧州の遺伝子編集技術市場(国別)

第7章 企業プロファイル

  • BRAIN Biotech AG
  • Cellectis S.A.
  • CRISPR Therapeutics AG
  • DNA Script
  • Magento, Inc.
  • Merck KGaA
図表

List of Figures

  • Figure 1: Europe Gene Editing Technologies Market, $Billion, 2022-2032
  • Figure 2: Europe Gene Editing Technologies Market: Drivers, Restraints, and Opportunities
  • Figure 3: Gene Editing Technologies Market (by Technology), $Billion, 2022-2032
  • Figure 4: Europe Gene Editing Technologies Market (by Application), $Billion, 2022-2032
  • Figure 5: Gene Editing Technologies Market (by Region), $Billion, 2022 and 2032
  • Figure 6: Gene Editing Technologies Market, Share of Key Developments and Strategies (by Category), January 2018- March 2023
  • Figure 7: Gene Editing Technologies Market: Research Methodology
  • Figure 8: Primary Research Methodology
  • Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 10: Top-Down Approach (Segment-Wise Analysis)
  • Figure 11: Gene Editing Technologies Market: Market Overview
  • Figure 12: Gene Editing Technologies Market, Potential Forecast Scenarios, 2022-2032
  • Figure 13: Gene Editing Technologies Market Size and Growth Potential (Realistic Scenario), $Million, 2022-2032
  • Figure 14: Gene Editing Technologies Market Size and Growth Potential (Optimistic Scenario), $Million, 2022-2032
  • Figure 15: Gene Editing Technologies Market Size and Growth Potential (Pessimistic Scenario), $Million, 2022-2032
  • Figure 16: Evolution of Gene Editing Technologies, 1994-2020
  • Figure 17: Clinical Trial Authorization for Gene Editing
  • Figure 18: Steps for Obtaining Marketing Authorization
  • Figure 19: EMA Review Timeline
  • Figure 20: Comparison of Various Gene Editing Technologies
  • Figure 21: Gene Editing Technologies Market, Technology Adoption Matrix
  • Figure 22: Key Strategies Adopted by Major Players, January 2018- March 2023
  • Figure 23: Gene Editing Technologies Market, Patent Analysis (by Year), January 2018- December 2022
  • Figure 24: Gene Editing Technologies Market, Patent Analysis (by Technology), January 2018- December 2022
  • Figure 25: Gene Editing Technologies Market, Patent Analysis (by Region), January 2018- December 2022
  • Figure 26: Gene Editing Technologies Market, Patent Analysis (by Country), January 2018- December 2022
  • Figure 27: Gene Editing Technologies Market (by Region)
  • Figure 28: Europe: Market Dynamics
  • Figure 29: Europe Gene Editing Technologies Market, $Billion, 2022-2032
  • Figure 30: Europe Gene Editing Technologies Market (by Application), $Billion, 2022-2032
  • Figure 31: Europe Gene Editing Technologies Market (by Technology), $Billion, 2022-2032
  • Figure 32: Germany Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 33: Germany Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 34: Germany Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 35: U.K. Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 36: U.K. Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 37: U.K. Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 38: Switzerland Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 39: Switzerland Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 40: Switzerland Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 41: France Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 42: France Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 43: France Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 44: Spain Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 45: Spain Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 46: Spain Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 47: Italy Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 48: Italy Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 49: Italy Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 50: Rest-of-Europe Gene Editing Technologies Market, $Million, 2022-2032
  • Figure 51: Rest-of-Europe Gene Editing Technologies Market (by Application), $Million, 2022-2032
  • Figure 52: Rest-of-Europe Gene Editing Technologies Market (by Technology), $Million, 2022-2032
  • Figure 53: BRAIN Biotech AG: Product Portfolio
  • Figure 54: BRAIN Biotech AG: Overall Financials, $Million, 2020-2022
  • Figure 55: BRAIN Biotech AG: Revenue (by Segment), $Million, 2020-2022
  • Figure 56: BRAIN Biotech AG: Revenue (by Region), $Million, 2020-2022
  • Figure 57: BRAIN Biotech AG: R&D Expenditure, $Million, 2020-2022
  • Figure 58: Cellectis S.A.: Product Portfolio
  • Figure 59: Cellectis S.A.: Overall Financials, $Million, 2020-2022
  • Figure 60: Cellectis S.A.: R&D Expenditure, $Million, 2020-2022
  • Figure 61: CRISPR Therapeutics AG: Product Portfolio
  • Figure 62: CRISPR Therapeutics AG: Overall Financials, $Million, 2020-2022
  • Figure 63: CRISPR Therapeutics AG: R&D Expenditure, $Million, 2020-2022
  • Figure 64: DNA Script: Product Portfolio
  • Figure 65: Magento, Inc.: Product Portfolio
  • Figure 66: Merck KGaA: Product Portfolio
  • Figure 67: Merck KGaA: Overall Financials, $Million, 2020-2022
  • Figure 68: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
  • Figure 69: Merck KGaA: Revenue (by Region), $Million, 2020-2022
  • Figure 70: Merck KGaA: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Key Questions Answered in the Report
  • Table 2: Parameters for Realistic, Optimistic, and Pessimistic Growth Scenarios
  • Table 3: Some of the Ongoing Clinical Trials Utilizing Various Gene Editing Technologies
  • Table 4: Expedited Regulatory Designations Around the World
  • Table 5: Gene Editing Technologies Market, Product Benchmarking (by Technology)
目次
Product Code: BHL1805SS

“The Europe Gene Editing Technologies Market Expected to Reach $3.26 Billion by 2032.”

Introduction to Europe Gene Editing Technologies Market

The Europe gene editing technologies market was valued at $0.37 billion in 2023 and is anticipated to reach $3.26 billion by 2032, witnessing a CAGR of 27.24% during the forecast period 2023-2032. The gene editing technologies market is anticipated to experience growth primarily due to the rising demand for personalized medicine. Furthermore, the introduction of novel technologies has further propelled the expansion of this market.

KEY MARKET STATISTICS
Forecast Period2023 - 2032
2023 Evaluation$0.37 Billion
2032 Forecast$3.26 Billion
CAGR27.24%

Market Introduction

The European gene editing technologies market is experiencing notable growth driven by the increasing demand for personalized medicine and the introduction of advanced technologies. Gene editing techniques are gaining prominence for their potential in tailoring medical treatments to individual patients, offering more effective therapies. Additionally, the emergence of novel gene editing technologies is enhancing precision and efficiency, making them increasingly valuable for research and clinical applications in Europe. The region's robust commitment to scientific research, biotechnology, and supportive regulatory frameworks creates a conducive environment for gene editing technology adoption. Ethical and responsible gene editing practices further ensure sustainable growth in this market. As gene editing continues to transform healthcare and life sciences, the European gene editing technologies market presents promising opportunities for scientific progress and therapeutic innovation.

Market Segmentation:

Segmentation 1: by Technology

  • CRISPR Gene Editing Technology
  • Non-CRISPR Gene Editing Technology

Segmentation 2: by Application

  • Agriculture
  • Biomedical

Segmentation 3: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Switzerland
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The gene editing technologies market (by technology) has been segmented into CRISPR gene editing technology and non-CRISPR gene editing technology. Moreover, the study provides the reader with a detailed understanding of the different applications of gene editing technologies in agricultural and biomedical.

Growth/Marketing Strategy: Gene editing technologies are being used for agricultural, biomedical, and other applications. Various companies are providing gene editing products and services, which is also the key strategy for market players to excel in the current gene editing technologies market.

Competitive Strategy: Key players in the Europe gene editing technologies market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe gene editing technologies market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Companies Profiled:

  • BRAIN Biotech AG
  • Cellectis S.A.
  • CRISPR Therapeutics AG
  • DNA Script
  • Magento, Inc.
  • Merck KGaA

Table of Contents

Executive Summary

1. Product Definition

  • 1.1. Inclusion and Exclusion Criteria

2. Market Scope

  • 2.1. Key Questions Answered in the Report

3. Research Methodology

4. Market Overview

  • 4.1. Market Overview
  • 4.2. Market Footprint and Potential Growth Scenario
    • 4.2.1. Realistic Growth Scenario
    • 4.2.2. Optimistic Growth Scenario
    • 4.2.3. Pessimistic Growth Scenario
  • 4.3. Evolution of Gene Editing Technologies
  • 4.4. Clinical Trials

5. Industry Outlook

  • 5.1. Regulatory Landscape
    • 5.1.1. Marketing Authorization
    • 5.1.2. USFDA Guidelines for BLA Submission
    • 5.1.3. Post-Authorization Regulations
  • 5.2. Legal Requirements and Frameworks in Europe
    • 5.2.1. EMA Biologics License Application Process
    • 5.2.2. Centralized Procedure
    • 5.2.3. Decentralized Procedure
    • 5.2.4. Mutual-Recognition Procedure
    • 5.2.5. National Procedure
  • 5.3. Expedited Regulatory Designations Around the World
  • 5.4. Product Benchmarking
    • 5.4.1. Product Benchmarking (by Technology)
    • 5.4.2. Comparative Analysis
  • 5.5. Technology Adoption Matrix
  • 5.6. Industry Trends
    • 5.6.1. Leveraging Collaboration as a Major Key Strategies to Create Opportunities for Gene Editing Technologies
    • 5.6.2. Growing Focus on Gene Therapies
  • 5.7. Patent Analysis
    • 5.7.1. Patent Analysis (by Year)
    • 5.7.2. Patent Analysis (by Technology)
    • 5.7.3. Patent Analysis (by Region)
    • 5.7.4. Patent Analysis (by Country)

6. Europe

  • 6.1. Overview
  • 6.2. Europe
    • 6.2.1. Europe Gene Editing Technologies Market (by Application)
    • 6.2.2. Europe Gene Editing Technologies Market (by Technology)
    • 6.2.3. Europe Gene Editing Technologies Market (by Country)
      • 6.2.3.1. Germany
        • 6.2.3.1.1. Germany Gene Editing Technologies Market (by Application)
        • 6.2.3.1.2. Germany Gene Editing Technologies Market (by Technology)
      • 6.2.3.2. U.K.
        • 6.2.3.2.1. U.K. Gene Editing Technologies Market (by Application)
        • 6.2.3.2.2. U.K. Gene Editing Technologies Market (by Technology)
      • 6.2.3.3. Switzerland
        • 6.2.3.3.1. Switzerland Gene Editing Technologies Market (by Application)
        • 6.2.3.3.2. Switzerland Gene Editing Technologies Market (by Technology)
      • 6.2.3.4. France
        • 6.2.3.4.1. France Gene Editing Technologies Market (by Application)
        • 6.2.3.4.2. France Gene Editing Technologies Market (by Technology)
      • 6.2.3.5. Spain
        • 6.2.3.5.1. Spain Gene Editing Technologies Market (by Application)
        • 6.2.3.5.2. Spain Gene Editing Technologies Market (by Technology)
      • 6.2.3.6. Italy
        • 6.2.3.6.1. Italy Gene Editing Technologies Market (by Application)
        • 6.2.3.6.2. Italy Gene Editing Technologies Market (by Technology)
      • 6.2.3.7. Rest-of-Europe
        • 6.2.3.7.1. Rest-of-Europe Gene Editing Technologies Market (by Application)
        • 6.2.3.7.2. Rest-of-Europe Gene Editing Technologies Market (by Technology)

7. Company Profiles

  • 7.1. BRAIN Biotech AG
    • 7.1.1. Company Overview
    • 7.1.2. Role of BRAIN Biotech AG in the Gene Editing Technologies Market
    • 7.1.3. Major Product: Key Specifications
    • 7.1.4. Key Competitors
    • 7.1.5. Financials
    • 7.1.6. Key Insights about the Financial Health of the Company
    • 7.1.7. Analyst Perspective
  • 7.2. Cellectis S.A.
    • 7.2.1. Company Overview
    • 7.2.2. Role of Cellectis S.A. in the Gene Editing Technologies Market
    • 7.2.3. Major Product: Key Specifications
    • 7.2.4. Key Competitors
    • 7.2.5. Financials
    • 7.2.6. Key Insights about the Financial Health of the Company
    • 7.2.7. Analyst Perspective
  • 7.3. CRISPR Therapeutics AG
    • 7.3.1. Company Overview
    • 7.3.2. Role of CRISPR Therapeutics AG in the Gene Editing Technologies Market
    • 7.3.3. Major Product: Key Specifications
    • 7.3.4. Key Competitors
    • 7.3.5. Financials
    • 7.3.6. Key Insights about the Financial Health of the Company
    • 7.3.7. Analyst Perspective
  • 7.4. DNA Script
    • 7.4.1. Company Overview
    • 7.4.2. Role of DNA Script in the Gene Editing Technologies Market
    • 7.4.3. Major Products: Key Specifications
    • 7.4.4. Key Competitors
    • 7.4.5. Analyst Perspective
  • 7.5. Magento, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Role of Magento, Inc. in the Gene Editing Technologies Market
    • 7.5.3. Major Products: Key Specifications
    • 7.5.4. Key Competitors
    • 7.5.5. Analyst Perspective
  • 7.6. Merck KGaA
    • 7.6.1. Company Overview
    • 7.6.2. Role of Merck KGaA in the Gene Editing Technologies Market
    • 7.6.3. Major Products: Key Specifications
    • 7.6.4. Key Competitors
    • 7.6.5. Financials
    • 7.6.6. Key Insights about the Financial Health of the Company
    • 7.6.7. Analyst Perspective